C.I. Medical Co.,Ltd.

    C.I. Medical Co.,Ltd.

    TTSE:3540
    1,492.00
    JPY
    0.00
    (0.00%)
    31.96P/E
    2015 Y
    2016 Y
    2017 Y
    2018 Y
    2019 Y
    2020 Y
    2021 Y
    2022 Y
    2023 Y
    2024 Y
    TTM
    Revenue per Share
    362.9
    406.68
    456.61
    516.14
    575.26
    747.86
    824.18
    857.83
    912.58
    1,349.89
    955.04
    Basic EPS, GAAP
    21.78
    25.65
    30.78
    26.6
    30.11
    58.4
    56.41
    50.42
    41.64
    125.32
    28.66
    Free Cash Flow per Basic Share
    13.87
    5.85
    14.36
    4.24
    22.85
    74.02
    -25.06
    -158.78
    -181.72
    98.58
    - -
    Dividend per Share
    - -
    - -
    2.56
    3.06
    2.66
    3
    11.68
    5.64
    5.04
    5.04
    - -
    Book Value per Share
    115.74
    141.33
    169.27
    192.81
    220.26
    275.66
    320.41
    365.18
    401.79
    522.09
    408.32
    Tangible Book Value per Share
    115.83
    139.9
    166.69
    184.64
    209.68
    261.4
    304.73
    331.46
    366.87
    516.07
    378.1
    Basic Weighted Avg Shares
    50
    50
    50
    50
    50
    50
    50
    50
    50
    50
    50
    Sales/Revenue/Turnover
    18,145
    20,334
    22,830
    25,807
    28,763
    37,393
    41,205
    42,891
    45,628
    67,493
    47,747
    Operating Margin (%)
    8.46
    8.81
    9.1
    7.43
    7.3
    12.58
    10.98
    9.3
    6.55
    3.7
    4.62
    Depreciation Expense
    136
    174
    227
    232
    288
    271
    345
    396
    1,022
    2,336
    - -
    Net Income, GAAP
    1,089
    1,283
    1,539
    1,330
    1,506
    2,920
    2,820
    2,521
    2,082
    6,266
    1,433
    Effective Tax Rate (%)
    32.43
    31.01
    29.48
    28.71
    29.94
    34.38
    34.17
    34.43
    34.05
    10.98
    33.95
    Profit Margin (%)
    6
    6.31
    6.74
    5.15
    5.23
    7.81
    6.84
    5.88
    4.56
    9.28
    3
    Working Capital
    4,454
    5,259
    6,713
    7,356
    8,668
    11,128
    10,930
    2,658
    -3,021
    -2,651
    -2,486
    LT Debt
    - -
    - -
    - -
    - -
    - -
    - -
    - -
    65
    64
    1,849
    77
    Total Equity
    5,861
    7,065
    8,425
    9,558
    10,944
    13,756
    15,978
    18,280
    20,139
    27,397
    20,513
    Return on Invested Capital (%)
    - -
    18.32
    18.1
    14.7
    13.94
    23.36
    18.89
    12.32
    6.19
    5.13
    4.34
    Return on Capital (%)
    - -
    19.92
    19.82
    14.69
    14.58
    23.55
    18.92
    12.2
    6.62
    14.62
    4.3
    Return on Common Equity (%)
    - -
    19.96
    19.82
    14.69
    14.58
    23.55
    18.92
    14.71
    10.86
    27.13
    7.23

    Capital Structure

    JPY

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    ST Debt
    17,129
    17,129
    19,129
    LT Borrowings
    64
    56
    77
    LT Finance Leases
    - -
    - -
    - -
    Preferred Equity and Hybrid Capital
    - -
    - -
    - -
    Shares Outstanding
    50
    50
    50
    Market Capitalization
    41,765
    39,727
    45,793

    Working Capital

    JPY

    •

    in mil. unless spec.
    Dec'23
    Mar'24
    Jun'24
    Total Current Assets
    17,848
    17,982
    20,861
    Cash, Cash Equivalents & STI
    1,804
    1,309
    6,242
    Accounts Receivable, Net
    3,289
    3,539
    3,568
    Inventories
    8,587
    8,664
    8,628
    Total Current Liabilities
    20,869
    21,410
    23,347
    Payables & Accruals
    - -
    - -
    - -
    ST Debt
    17,129
    17,129
    19,129
    Deferred Revenue
    - -
    - -
    - -

    Growth Rates

    JPY

    •

    in mil. unless spec.

    (avg. rate of change)

    10 years
    5 years
    1 year
    Total Equity
    - -
    20.49%
    36.04%
    Free Cash Flow
    - -
    96.77%
    -154.25%
    Net Income, GAAP
    - -
    52.69%
    200.96%
    Sales/Revenue/Turnover
    - -
    19.72%
    47.92%
    Total Cash Common Dividend
    - -
    - -
    - -

    Quarterly Revenue

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    10,999
    11,198
    11,451
    11,980
    45,628
    2024
    11,946
    12,370
    - -
    - -
    67,493
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Earnings Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    10.42
    - -
    - -
    - -
    41.64
    2024
    4.94
    - -
    - -
    - -
    125.32
    2025
    - -
    - -
    - -
    - -
    - -

    Quarterly Dividends Per Share

    JPY

    •

    in mil. unless spec.

    Year

    Q1
    Q2
    Q3
    Q4
    FY
    2023
    - -
    - -
    - -
    - -
    5.04
    2024
    - -
    - -
    - -
    - -
    5.04
    2025
    - -
    - -
    - -
    - -
    - -

    Company Description

    Address
    Similar Companies
    Business